The long duration of action and decreased incidence of hypoglycemia provide potential advantages for its use in pregnancy. However, the placental pharmacokinetics of insulin glargine have not been ...

University of Wisconsin researchers and collaborators recently published a feasibility study that focuses on limiting fetal growth restriction in nonhuman primates through nanoparticle injections of ...